Key facts
- This page summarizes Watson David O's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Feb 2022, 17:03.
Watson David O - 28 Jan 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)
- Reporting relationship
- General Counsel
- Issuer ticker
- APLS
- Reported as of
- 28 Jan 2022
- Net transaction value
- -$25,084
- SEC form
- 4
- Accepted by SEC
- 01 Feb 2022, 17:03:02 UTC
- Prior SEC filing
- 25 Jan 2022
- Next SEC filing
- 14 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Watson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Watson David O filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 01 Feb 2022.
Change
- Previous filing in this sequence was filed on 25 Jan 2022.
- Current net transaction value: -$25,084.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APLS
transaction
Common Stock
Tax liability
- Transaction value
- $25,084
- Shares
- -650
- Change %
- -0.49%
- Price
- $38.59
- Shares after
- 132,935
- Date
- 28 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
APLS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 28 Jan 2022
- Ownership
- See Footnote
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This represents shares used to cover tax withholding on a Restricted Stock Unit release.
Footnote F2
The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.